Carbon nanotubes: A potential concept for drug delivery applications

Recent Patents on Drug Delivery and Formulation

Volumn 8, Issue 1, 2014, Pages 12-26

  Kumar, Rakesh ^a   Dhanawat, Meenakshi ^b   Kumar, Sudhir ^a   Singh, Brahma N ^c   Pandit, Jayant K ^d   Sinha, Vivek R ^a  

^a PANJAB UNIVERSITY   (India)

^b MEWAR UNIVERSITY   (India)

^c FOREST RESEARCH INSTITUTE   (United States)

^d BANARAS HINDU UNIVERSITY   (India)

Author keywords

Carbon nanotubes; Drug delivery; Functionalization; Toxicity

Indexed keywords

AMPHOTERICIN B; ASCORBIC ACID; BOVINE SERUM ALBUMIN; CARBOHYDRATE; CARBON NANOTUBE; CISPLATIN; CLONIDINE; DAPSONE; DEXAMETHASONE; DILTIAZEM; DOXORUBICIN; ERYTHROPOIETIN; FERRITIN; INDOMETACIN; IRINOTECAN; ISONIAZID; NICOTINAMIDE; NIFEDIPINE; NIMESULIDE; OXALIPLATIN; PACLITAXEL; PIRARUBICIN; PROTOPORPHYRIN; STREPTAVIDIN; BIOMATERIAL;

ARTICLE; CELL INTERACTION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; ENDOCYTOSIS; GENE TARGETING; HUMAN; IMMOBILIZATION; INTERNALIZATION; IONTOPHORESIS; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; CHEMISTRY; PATENT; TRANSPORT AT THE CELLULAR LEVEL;

BIOCOMPATIBLE MATERIALS; BIOLOGICAL TRANSPORT; DRUG DELIVERY SYSTEMS; HUMANS; NANOTUBES, CARBON; PATENTS AS TOPIC;

EID: 84900538780     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872211308666140124095745     Document Type: Article

References (126)

1. Liversidge EM, Liversidge GG, Cooper ER. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2005; 18: 113-20.
2. Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: Rational for drug development and what can we expect for the future. Adv Drug Deliv Rev 2001; 47: 3-19.
3. Muqbil I, Masood A, Sarkar FH, Mohammad RM, Azmi AS. Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents. Cancers 2011; 3: 428-45.
4. Bhowmik D, Chiranjib, Jayakar RMB. Role of nanotechnology in novel drug delivery system. J Pharm Sci Tech 2009; 1: 20-35.
5. Nanomedicine. National institutes of health. U.S. department of health and human services. Available at: http://commonfund.nih.gov/nanomedicine/overview.aspx (Accessed on: March 25, 2011).
6. Carbon. Encyclopaedia Britannica. Available at: http://www.britannica.com/EBchecked/topic/94732/carbon/1118/Propertiesand-uses (Accessed on: April 10, 2011).
7. Iijima S. Helical microtubules of graphitic carbon. Nature 1991; 354: 56-8.
8. Su JW, Fu SJ, Gwo S, Lin KJ. Fabrication of porous carbon nanotube network. Chem Commun 2008; 43:5631-2.
9. Klumpp C, Kostareolos K, Prato M, Bianco A. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim Biophys Acta 2006; 1758: 404-12.
10. John G, Masuda M, Okada Y, Yase K, Shimizu T. Nanotube formation from renewable resources via coiled nanofibers. Adv Mater 2001; 13: 715-8.
11. Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res 2008; 41: 60-8.
12. Skrabalak SE, Suslick KS. Porous carbon powders prepared by ultrasonic spray pyrolysis. J Am Chem Soc 2006; 128: 12642-3.
13. Baughman RH, Zakhidov AA, De Heer WA. Carbon nanotubes-the route toward applications. Science 2002; 297: 787-92.
14. Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 2005; 9: 674-9.
15. Bianco A, Prato M. Can carbon nanotubes be considered useful tools for biological applications? Adv Mater 2003; 20:1765-8.
16. Guo Z, Sadler PJ, Tsang SC. Immobilization and visualization of DNA and proteins on carbon nanotubes. Adv Mater 1998; 10: 701-3.
17. Hou PX, Liu C, Cheng HM. Purification of carbon nanotubes. Carbon 2008; 46: 2003-25.
18. Xiaoming S, Zhuang L, Kevin W, Robinson JT, Goodwin A, Zaric S, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008; 1: 203-12.
19. Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: Theranostic applications. Chem Soc Rev 2013; 42: 530-47.
20. Foldvari M, Bagonluri M. Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties. Nanomedicine: NBM 2008a; 4: 173-82.
21. Foldvari M, Bagonluri M. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine: NBM 2008b; 4: 183-200.
22. Mauter MS, Elimelech M. Environmental applications of carbonbased nanomaterials. Am Chem Soc 2008; 42: 5843-59.
23. Hirsch A, Vostrowsky O. Functionalization of Carbon Nanotubes. Top Curr Chem 2005; 245: 193-237.
24. Zha YL, Stoddart JF. Non-covalent functionalization of single walled carbon nanotubes. Acc Chem Res 2009; 42: 1161-71.
25. Chen RJ, Zhang Y, Wang D, Dai H. Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc 2001; 123: 3838-9.
26. Tasis D, Tagmatarchis N, Bianco A, Prato M. Chemistry of carbon nanotubes. Chem Rev 2006; 106: 1105-36.
27. Georgakilas V, Kordatos K, Prato M, Guldi DM, Holzinger M, Hirsch A. Organic functionalization of carbon nanotubes. J Am Chem Soc 2002; 124: 760-1.
28. Tour, J.M., Hudson, J.L., Dyke, C.R., Stephenson, J.J. Functionalization of carbonnanotubes in acidic media US20070280876A1 (2007).
29. Martinez-Rubi, Y., Guan, J., Simard, B. Chemical functionalization of carbon anotubes US20090306427A1 (2009).
30. Dai, H., Chen, R.J. Noncovalent sidewall functionalization of carbon nanotubes US8029734B2 (2011).
31. Ostojic, G., Hersam, M.C. Functionalization of carbon nanotubes with metallic moieties US20100173376A1 (2010).
32. Gao, H., Kong, Y., Cui, D., Ozkan, C.O. Encapsulation of biomolecules inside carbon nanotubes EP1493714A1 (2005).
33. Lacerdaa L, Raffa S, Pratoc M, Bianco A, Kostarelos K. Cellpenetrating CNTs for delivery of therapeutics. Nano Today 2007; 2: 38-43.
34. Ladeira, L.O., Rodrigues, L., Jnr. Correa, A. Carbon nanotube conjugate for inhibiting pathogenic infection structures in plants WO2011079356A1 (2011).
35. Scheinberg, D.A., Mcdevitt, M.R., Villa, C.H., Mulvey, J.J. Targeted self-assembly of functionalized carbon nanotubes on tumors WO2013101983A2 (2013).
36. Raffa V, Ciofani G, Nitodas S, et al. Can the properties of carbon nanotubes influence their internalization by living cells? Carbon 2008; 46: 1600-10.
37. Mu Q, Broughton DL, Yan B. Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: Developing a model for cell uptake. Nano Lett 2009; 9: 4370-5.
38. Antonelli A, Serafini S, Menotta M, Sfara C, Pierigé F, Giorgi L, et al. Improved cellular uptake of functionalized single-walled carbon nanotubes. Nanotechnology 2010; 21: 425101 (14pp).
39. Chiles, T.C. Method for molecular delivery into cells using nanotubes spearing US20090311767A1 (2009).
40. Draper, R.K., Pantano, P., Wang, R.H., Mikoryak, C. Method for measuring carbon nanotubes taken-up by a plurality of living cells US20110203927A1 (2011).
41. Lin, H.C., Lin, H.H., Kao, C.Y., Yu, L., Peng, W.P., Chen, C.H. Quantitative measurement of nano/micro particle endocytosis with cell mass spectrometry. US20110236882A1 (2011).
42. Chen X, Schluesener HJ. Multi-walled carbon nanotubes affect drug transport across cell membrane in rat astrocytes. Nanotechnology 2010; 2: 105104(10pp).
43. Heister E, Neves V, Tîlmaciu C, Lipert, K, Beltran, VS, Coley, HM, et al. Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy. Carbon 2009; 47: 2152-60.
44. Zhang X, Meng L, Lu Q, Fei Z, Dyson PJ. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 2009; 30: 6041-7.
45. Tripisciano C, Kraemer K, Taylor A, Borowiak-Palen E. Singlewall carbon nanotubes based anticancer drug delivery system. Chem Phys Lett 2009; 478: 200-5.
46. Bhirde AA, Patel V, Gavard J, Zhang G, Sousa AA, Masedunskas A, et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009; 3: 307-16.
47. Liu Z, Chen K, Davis C, Sarah S, Qizhen C, Xiaoyuan C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008; 68: 6652-60.
48. McDevitt MR, Chattopadhyay D, Kappel BJ, Jaggi JS, Schiffman SR, Antczak C, et al. Tumor targeting with antibodyfunctionalized, radiolabeled carbon nanotubes. J Nucl Med 2007; 48: 1180-9.
49. Chen G, He Y, Wu X, Zhang Y, Luo C, Jing P. In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer. Braz J Med Biol Res 2012; 45: 771-6.
50. Wu L, Man C, Wang H, Lu X, Ma Q, Cai Y, et al. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin. Pharm Res 2013; 30: 412-23.
51. Zhou M, Peng Z, Liao S, Li P, Li S. Design of microencapsulated carbon nanotube-based microspheres and its application in colon targeted drug delivery. Drug Deliv 2013. DOI: 10.3109/10717544.2013.834413.
52. Zanella I, Fagan SB, Mota R, Fazzio A. Ab initio study of pristine and Si-doped capped carbon nanotubes interacting with nimesulide molecules. Chem Phys Lett 2007; 439: 348-53.
53. Madaenia SS, Derakhshandeh K, Ahmadia S, Vatanpoura V, Zinadinia S. Effect of modified multi-walled carbon nanotubes on release characteristics of indomethacin from symmetric membrane coated tablets. J Memb Sci 2012; 389: 110-6.
54. Nakamura M, Tahara Y, Ikehara Y, Murakami T, Tsuchida K, Iijima S, et al. Single-walled carbon nanohorns as drug carriers: Adsorption of prednisolone and anti-inflammatory effects on arthritis. Nanotechnology 2011; 22: 465102.
55. Naficy S, Razal JM, Spinks GM, Wallace GG. Modulated release of dexamethasone from chitosan-carbon nanotube films. Sens Actuators A Phys 2009; 155: 120-4.
56. Liu H, Bu Y, Mi Y, Wang Y. Interaction site preference between carbon nanotube and nifedipine: A combined density functional theory and classical molecular dynamics study. Theochem 2009; 90: 163-8.
57. Ensafi AA, Karimi-Maleh H, Mallakpour S, Rezaei B. Highly sensitive voltammetric sensor based on catechol-derivativemultiwall carbon nanotubes for the catalytic determination of captopril in patient human urine samples. Colloids Surf B Biointerfaces 201; 87: 480-8.
58. Li Y, Wang T, Wang J, Jiang T, Cheng G, Wang S. Functional and unmodified MWNTs for delivery of the water-insoluble drug Carvedilol-A drug-loading mechanism. Appl Surf Sci 2011; 257: 5663-70.
59. Strasinger CL, Scheff NN, Wu J, Hinds BJ, Stinchcomb AL. Carbon nanotube membranes for use in the transdermal treatment of nicotine addiction and opioid withdrawal symptoms. Subst Abuse 2009; 3: 31-9.
60. Bhunia T, Giri A, Nasim T, Chattopadhyay D, Bandyopadhyay A. A transdermal diltiazem hydrochloride delivery device using multiwalled carbon nanotube/poly (vinyl alcohol) composites. Carbon 2013; 52: 305-15.
61. Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand JP, et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int 2005; Ed 44: 6358-62.
62. Vukovic GD, Tomic SZ, Marinkovic AD, Velimir Radmilović, Petar S. Uskoković, Miodrag Čolić. The response of peritoneal macrophages to dapsone covalently attached on the surface of carbon nanotubes. Carbon 2010; 48: 3066-78.
63. Gallo M, Favila A, Mitnik DG. DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. Chem Phys Lett 2007; 447: 105-9.
64. Li H, Zhang D, Han X, Xing B. Adsorption of antibiotic ciprofloxacin on carbon nanotubes: pH dependence and thermodynamics. Chemosphere 2013. DOI: 10.1016/j.chemosphere.2013.08.053.
65. Banerjee I, Douaisi MP, Mondal D, Kane RS. Light-activated nanotube-porphyrin conjugates as effective antiviral agents. Nanotechnology 2012; 23: 105101.
66. Venkatesan N, Yoshimitsu J, Ito Y, Shibata N, Takada K. Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. Biomaterials 2005; 26: 7154-63.
67. Jiang K, Schadler LS, Siegel RW, Zhanfg X, Zhang H, Terrones M. Protein immobilization on carbon nanotubes via a two-step process of diimide-activated amidation. J Mater Chem 2004; 14: 37-9.
68. Pantarotto D, Partidos CD, Graff R, Johan H, Jean-Paul B, Maurizio P, et al. Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides. J Am Chem Soc 2003; 125: 6160-4.
69. Liu Z, Galli F, Janssen KGH, Linhua J, Heiko JL, Daniël CG, et al. Stable single-walled carbon nanotube-streptavidin complex for biorecognition. J Phys Chem 2010; 114: 4345-52.
70. Weng X, Wang M, Ge J, Yu S, Liu B, Zhong J, et al. Carbon nanotubes as a protein toxin transporter for selective HER2-positive breast cancer cell destruction. Mol BioSyst 2009; 5: 1224-31.
71. Li C, Yang K, Zhang Y, Hao T, Feng Y, Liang T, et al. Highly biocompatible multi-walled carbon nanotube-chitosan nanoparticle hybrids as protein carriers. Acta Biomater 2011; 7: 3070-7.
72. Kostarelos K, Miller AD. Synthetic, self-assembly ABCD nanoparticles: A structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev 2005; 34: 970-94.
73. Singh R, Pantarotto D, McCarthy D. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: Towards the construction of nanotube-based gene delivery vectors. J Am Chem Soc 2005; 127: 4388-96.
74. Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed 2004; 43: 5242-6.
75. Bi-Feng P, Da-Xiang C, Ping X, Chen H, Liu F-T, Li Q, et al. Design of dendrimer modified carbon nanotubes for gene delivery. Chin J Canc Res 2007; 19: 1-6.
76. Gao L, Nie L, Wang T, Qin Y, Guo Z, Yang D, et al. Carbon nanotube delivery of the GFP gene into mammalian cells. Chem Bio Chem 2006; 7: 239-42.
77. Zhang Z, Yang X, Zhang Y, Bin Z, Shujing W, Tianhui Z, et al. Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth. Clin Cancer Res 2006; 12: 4933-9.
78. Al-Jamal KT, Toma FM, Yilmazer A, Ali-Boucetta H, Nunes A, Herrero MA, et al. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube: siRNA complexes. FASEB J 2010; 24: 4354-65.
79. Cai D, Doughty CA, Potocky TB, Fay JD, Zhongping H, Derek B, et al. Carbon nanotube-mediated delivery of nucleic acids does not result in non-specific activation of B lymphocytes. Nanotechnology 2007; 18: 365101 (10pp).
80. Ojea-Jimenez I, Tort O, Lorenzo J, Puntes VF. Engineered nonviral nanocarriers for intracellular gene delivery applications. Biomed Mater 2012; 7: 054106.
81. Qin W, Yang K, Tang H, Tan L, Xie Q, Ma M, et al. Improved GFP gene transfection mediated by polyamidoamine dendrimerfunctionalized multi-walled carbon nanotubes with high biocompatibility. Colloids Surf B Biointerfaces 2011; 84: 206-13.
82. Shen W, Wang H, Guan R, Li Z. Surface modification of activated carbon fiber and its adsorption for vitamin B1 and folic acid. Colloids Surf A Physicochem Eng Asp 2008; 331: 263-7.
83. De Menezes VM, Fagan SB, Zanella I, Mota R. Carbon nanotubes interacting with vitamins: First principles calculations. Microelectron J 2009; 40: 877-9.
84. Chambers G, Carroll C, Farrell GF, Alan BD, Mary MN, Marcinhet P, et al. Characterization of the interaction of gamma cyclodextrin with single-walled carbon nanotubes gordon chambers. Nano Lett 2003; 3: 843-6.
85. Chen X, Tam UC, Czlapinski JL, Lee GS, Rabuka D, Zettl A, et al. Interfacing carbon nanotubes with living cells. J Am Chem Soc 2006; 128: 6292-3.
86. Gu L, Luo PG, Wang H, Meziani MJ, Lin Y, Veca LM, et al. Single-walled carbon nanotube as a unique scaffold for the multivalent display of sugars. Biomacromolecules 2008; 9: 2408-18.
87. Assali M, Leal MP, Fernandez I, Romero-Gomez P, Baati R, Khiar N. Improved non-covalent biofunctionalization of multi-walled carbon nanotubes using carbohydrate amphiphiles with a butterflylike polyaromatic tail. Nano Res 2010; 3: 764-78.
88. Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010; 62: 1064-79.
89. Janib SM, Moses AS, MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 2010; 62: 1052-63.
90. Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, et al. Nanomedicines as cancer therapeutics: Current status. Curr Cancer Drug Targets 2013; 13: 362-78.
91. Akhter S, Ahmad Z, Singh A, Ahmad I, Rahman M, Anwar M, et al. Cancer targeted metallic nanoparticle: Targeting overview, recent advancement and toxicity concern. Curr Pharm Des 2011; 17: 1834-50.
92. Vatansever F, Chandran R, Sadasivam M, Chiang LY, Hamblin MR. Multi-Functionality in Theranostic Nanoparticles: Is more Always Better? J Nanomed Nanotechnol 2012. DOI: 10.4172/2157-7439.1000e120.
93. Bhirde AA, Liu G, Jin A, Iglesias-Bartolome R, Sousa AA, Leapman RD, et al. Combining portable Raman probes with nanotubes for theranostic applications. Theranostics 2011; 1: 310-21.
94. Mashal A, Sitharaman B, Li X, Avti PK, Sahakian AV, Booske JH, et al. Toward carbon-nanotube-based theranostic agents for micro wave detection and treatment of breast cancer: Enhanced dielectric and heating response of tissue-mimicking materials. IEEE Trans Biomed Eng 2010; 57: 1831-4.
95. Das M, Datir SR, Singh RP, Jain S. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic acidmultiwalled carbon nanotube conjugate. Mol Pharm 2013; 10: 2543-57.
96. Yang M, Meng J, Cheng X, Lei J, Guo H, Zhang W, et al. Multiwalled carbon nanotubes interact with macrophages and influence tumor progression and metastasis. Theranostics. 2012; 2(3): 258-70.
97. Khabashesku, V.N., Peng, H., Margrave, J.L., Margrave, M.L. Nanotube-amino acids and methods for preparing same. US20100047575A1 (2010).
98. Atyabi, F., Ateli, M., Sobhani, Z., Dinarvand, R., Ghahremani, M.H. Poly (citric acid) functionalized carbon nanotube drug delivery system. US20100324315A1 (2010).
99. Gharib, M., Aria, A.M., Beizai, M. Drug delivery by cabon nanotube arrays. US20120058170A1 (2012).
100. Hirsch, A., Sagman, U., Wilson, S.R., Rosenblum, M.G., Wilson, L.J. Use of carbon nanotube for drug delivery. US20080193490A1 (2008).
101. Jennings, J.A., Haggard, W.O., Bumgardner, J.D. Chitosan/carbon nanotube composite scaffolds for drug delivery. US20100266694A1 (2010).
102. Tour, J.M., Moore, V.C., Casscella, S.W., et al. Water-soluble carbon nanotube composition for drug delivery and medicinal applications. US20090170768A1 (2009).
103. Jagota, A., Lustig, A.R., Wang, S., Wang, H. Carbon nanotube binding peptides. US20070117150A1 (2007).
104. Mohapatra, S.S., Kumar, A. Method of drug delivery by carbon nanotube-chitosan nanocomplexes. US20080214494A1 (2008).
105. Chen, W.R. Immunologically modified carbon nanotubes for cancer treatment. US20120220921A1 (2012).
106. Harrison, R.G., Resasco, D.E. Compositions and methods for cancer treatment using targeted carbon nanotubes. US20100184669A1 (2010).
107. Powis G., Bartholomeusz, J., Tour, J., Schmidt, H., Cherukuri, P., Weisman, R.B. Single-walled carbon nanotube/bioactive complexes and methods related thereto. US20130058984A1 (2013).
108. Dai, H., Kam, N.W.S., Wender, P.A., Liu, Z. Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells. US20130034610A1 (2013).
109. Kim, S.S., Noh, Y.H., Yoon, O.J., Yoo, S.H. Carbon nanotubes serving as stem cell scaffold. US20090148417A1 (2009).
110. Chen, J., Wong, S.S., Ojima, I. Carbon nanotube-based drug delivery systems and methods of making same. US20100021471 (2010).
111. Jeong, Y., Lee, H.J., Lee, D.Y. Use of carbon nanotubes for preventing or treating brain disease. EP2594289A2 (2013).
112. Ying Z, Xin LW. Cytotoxicity of carbon nanotubes. Sci China Ser B-Chem 2008; 51: 1021-9.
113. Chen, F. Toxicology and Cellular Effect of Manufactured Nanomaterials. US20120315218A9 (2012).
114. Cui HF, Vashist SK, Al-Rubeaan OK, Luong JH, Sheu FS. Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues. Chem Res Toxicol 2010; 23: 1131-47.
115. Khang, D.W., Kim, S.H., Lee, S.Y., et al. Method for preparing a highly dispersive carbon nanotube for reducing in vivo immunotoxicity. WO2012057511A2 (2012).
116. Ursini CL, Cavallo D, Fresegna AM, Ciervo A, Maiello R, Buresti G, et al. Comparative cyto-genotoxicity assessment of functionalized and pristine multiwalled carbon nanotubes on human lung epithelial cells. Toxicol In vitro 2012; 26: 831-40.
117. Khang, D.W., Nam, T.H. Carbon nanotube polymer composite coating film which suppresses toxicity and inflammation and has improved biocompatibility and adjusted surface strength. WO2012060592A2 (2012).
118. Meng L, Jiang A, Chen R, Li CZ, Wang L, Qu Y, et al. Inhibitory effects of multiwall carbon nanotubes with high iron impurity on viability and neuronal differentiation in cultured PC12 cells. Toxicology 2013; 313: 49-58.
119. Goto, H., Furuta, T., Fujiwara, Y., Ohashi, T. Method of purifying single wall carbon nanotubes. US7135158B2 (2006).
120. Bae, E.J., Min, Y.S., Park, W.J. Method of removing carbonaceous impurities in carbon nanotubes. US7604790B2 (2009).
121. Allen BL, Kichambare PD, Gou P, Vlasova II, Kapralov AA, Konduru N, et al. Biodegradation of single-walled carbon nanotubes through enzymatic catalysis. Nano Lett 2008; 8: 3899-903.
122. Kagan VE, Konduru NV, Feng W, Allen BL, Conroy J, Volkov Y, et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat Nanotechnol 2010; 5: 354-9.
123. Kotchey GP, Gaugler JA, Kapralov AA, Valerian E. Kagan VE, Star A. Effect of antioxidants on enzyme-catalysed biodegradation of carbon nanotubes. J Mater Chem B 2013; 1: 302-9.
124. Kotchey GP, Hasan SA, Kapralov AA, Ha SH, Kim K, Shvedova AA, et al. A natural vanishing act: The enzyme-catalyzed degradation of carbon nanomaterials. Acc Chem Res 2012; 45: 1770-81.
125. Allen BL, Kotchey GP, Chen Y, Yanamala NV, Klein-Seetharaman J, Kagan VE, et al. Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes. J Am Chem Soc 2009; 131: 17194-205.
126. Bianco A, Kostarelos K, Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem Commun (Camb) 2011; 47: 10182-8.